home site map e-mail
216-831-5700 / 800-622-8521

 
Retina Associates - Research Coordinators
 
Select display options below. (Cookies need to be enabled in your browser!)
Colors: High contrast    Default    Font Size: X-Large    Large    Medium    Default    Small   
 
 
» QUICK LINKS
Select a link below for details.

» Age-related Macular Degeneration

» Diabetic Retinopathy

» Retinal Vein Occlusion

» Other Diagnoses

 
» RESEARCH & CLINICAL TRIALS

Study Detail: High Myopia

Trial Description

Summary : Study of the effectiveness of Macugen versus Photodynamic Laser Therapy (PDT) in the prevention of vision loss in patients with abnormal blood vessels in the eye (Subfoveal CNV) related to pathological myopia.

Basic Trial Information

Phase

Disease

Status

Age

Sponsor

Protocol #

NA

Pathological myopia

Enrolling

> 18 yrs

Eyetech

NA

Study Duration: 54 weeks

Eligibility Criteria:

Inclusion Criteria

  • All angiographic subtypes of Subfoveal CCNV secondary to high myopia.
  • High myopia of 6 D of spherical equivalent though eyes with spherical equivalent of less than 6 D are eligible if retinal abnormalities consistent with pathologic myopia are present and the axial length is at least 26mm.
  • SE best correction of 20/40 or worse.
  • Check with study coordinator for other inclusion criteria

Exclusion Criteria

  • More than one PDT treatment
  • PDT treatment done within 3 months- must wait to enroll after the 3 month period
  • Check with study coordinator for other exclusion criteria

Study Title : Macugen in Myopic Degeneration

 

Trial Contact Information

Site

Study Coordinator

Beachwood

Vivian 216/831-5704 ext. 6800

Lakewood

Susan R. 216/831-5704 ext. 6800

Youngstown

Tami H. 216/831-5704 ext. 6800